Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warning Letters
Manufacturing
Viatris says India plant hit with FDA warning letter, import ban
Viatris disclosed its production site in India was issued a warning letter by the FDA, which also banned 11 products from being imported into the U.S.
Joseph Keenan
Dec 23, 2024 10:50am
FDA slams Indian drugmaker Unexo with warning letter
Nov 20, 2024 9:25am
FDA scrutinizes Novo on production issues at semaglutide plant
Oct 31, 2024 9:33am
FDA issues Form 483s to Japanese, Indian drugmakers
Sep 10, 2024 8:50am
EyePoint's Yutiq production lands in the FDA's crosshairs
Aug 27, 2024 4:07pm
FDA rebukes troubled Eugia production site with a warning letter
Aug 19, 2024 8:10am